3dGRO® Human iPSC-derived Liver Progenitor Organoids are derived from integration-free human induced pluripotent stem cells (iPSC, Cat No. SCC271) reprogrammed using the Simplicon RNA reprogramming technology (Cat. No. SCR550). Human iPSC cells were differentiated using a multi-step process from definitive endoderm to hepatic endoderm and eventually into liver progenitor organoids. These liver progenitor organoids are polarized self-organizing, 3D structures that can be expanded in long-term culture and cryo-preservable. These liver progenitor organoids show persistent growth and expansion post cryo-preservation. 3dGRO® human iPSC-derived liver progenitor organoids (Cat. No. SCC572) can be propagated long-term by passaging every 8-10 days using 3dGRO® Human Liver Progenitor Organoid Expansion Media (Cat. no. SCM313).
Product Specifications:
| Specification | Value |
| 3dGRO® human iPSC-derived liver progenitor organoids | Cat. No. SCC572 |
| Biological Source | Human |
| Quality Level | 100 |
| Packaging | vial of ≥1500 vial (viable cells per vial) |
| Manufacturer/Tradename | Millipore |
| Technique(s) | cell culture | stem cell: suitable |
| Shipped In | liquid nitrogen |
| Storage Temp. | −196°C |
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.
